Overview:
This Powerpoint by the MAPS Evidence Generation Focus Area Working Group offers a comprehensive overview of Real World Evidence (RWE) and its evolving use in the biopharmaceutical industry.
Authors:
Dr. Phil Wakefield
Global Medical Strategy & Value Lead, MEDiSTRAVA
Medical Affairs Professional Society
Clément François, MSc. PhD
Executive Vice President, Pricing and Market Access, Creativ-Ceutical | A MEDiSTRAVA Company
Medical Affairs Professional Society
Agathe Leray
Vice President, Global Business Development, Creativ-Ceutical | A MEDiSTRAVA Company
Medical Affairs Professional Society
Ann Hartry, PhD
VP, Deputy Head Global Value Evidence, Lundbeck
Medical Affairs Professional Society
